Application of hot-melt coating process for designing a lipid based controlled release drug delivery system for highly aqueous soluble drugs

Chemical and Pharmaceutical Bulletin

Volumn 57, Issue 5, 2009, Pages 464-471

  Knezevic, Zdravka ^a   Gosak, Darko ^b   Hraste, Marin ^a   Rausl, Dragica ^b   Khan, M Zahirul I ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b Research and Development   (Croatia)

^c Asia Pacific Tourism Consultants   (Australia)

Author keywords

Controlled release; Design space; Hot melt coating process; Lipid matrix; Paracetamol; Pharmaceutical product design

Indexed keywords

LACTOSE; LIPID; PARACETAMOL;

ARTICLE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; FLUIDIZATION; IN VITRO STUDY; IN VIVO STUDY; PH MEASUREMENT;

DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HOT TEMPERATURE; KINETICS; LIPIDS; MICROSCOPY, ELECTRON, SCANNING; SOLUBILITY; SURFACE PROPERTIES; WATER;

EID: 65949086141     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.57.464     Document Type: Article

References (33)

1. Brodkey R. S., Hershey H. C., "Transport Phenomena," McGraw Hill Publisher, New York, 1989.
2. Tarvainen M., Peltonen S., Mikkonen H., Elovaara M., Tuunainen M., Paronen P., Ketolainen J., Sutinen R., J. Controlled Release, 96, 179-191 (2004).
3. Khan M. Z. I., Prebeg Z., Kurjakovic N., J. Controlled Release, 58, 215-222 (1999).
4. Riedel A., Leopold C. S., Drug Dev. Ind. Pharm., 31, 151-160 (2005).
5. Barthelemy P., Laforet J. P., Farah N., Joachim J., Eur. J. Pharm. Biopharam., 47, 87-90 (1999).
6. Faham A., Prinderre P., Piccerelle P., Farah N., Joachim J., Pharmazie, 55, 444-448 (2000).
7. Faham A., Prinderre P., Farah N., Eichler K. D., Kalantzis G., Joachim J., Drug Dev. Ind. Pharm., 26, 167-176 (2000).
8. Nuttanan S., Varaporn J., Ampol M., Powder Technology, 141, 203-209 (2004).
9. Delgado Charro M. B., Vila Jato J. L., Int. J. Pharm., 78, 35-41 (1992).
10. Shear M. J., Am. J. Cancer, XXVI, 322-332 (1936).
11. Kincl F. A., Sundaram K., Chang C. C., Rudel H. W., Acta Endocrinol., 64, 253-264 (1970).
12. Wang P. Y., Diabetes, 36, 1068-1072 (1987).
13. Khan M. Z. I., Tucker I. G., Opdebeeck J. P., Int. J. Pharm., 76, 161-170 (1991).
14. Khan M. Z. I., Tucker I. G., Opdebeeck J. P., Int. J. Pharm., 90, 255-262 (1993).
15. Choy J. W., Khan N., Yuen K. H., Int. J. Pharm., 299, 55-64 (2005).
16. Li F. Q., Hu J. H., Deng J. X., Su H., Xu S., Liu J. Y., Int. J. Pharm., 324, 152-157 (2006).
17. Perez M. A., Ghaly E. S., Marti A., P. R. Health Sci. J., 12, 263-267 (1993).
18. Zhang Y. E., Schwartz J. B., Drug Dev. Ind. Pharm., 29, 131-138 (2003).
19. Goole J., Vanderbist F., Amighi K., Int. J. Pharm., 334, 35-41 (2007).
20. Jannin V., Berard V., N'Diaye A., Andres C., Pourcelot Y., Int. J. Pharm., 262, 39-45 (2003).
21. Khan M. Z. I., Krajacic A., Vodopija S., Knezevic Z., Patent Application WO 2003/074033, (2003).
22. Wei J., "Product Engineering: Molecular Structure and Properties," Oxford University Press, New York, 2007.
23. Cussler E. L., Moggridge G. D., "Chemical Product Design," Cambridge University Press, New York, 2001.
24. Yu L. X., Pharm. Res., 25, 781-791 (2008).
25. Higuchi T., J. Pharm. Sci., 52, 1145-1149 (1963).
26. Khan G. M., Meidan V. M., Drug Dev. Ind. Pharm., 33, 627-639 (2007).
27. Geldart D., Powder Technology, 7, 282-292 (1973).
28. Knezevic Z., Gosak D., Hraste M., Jalsenjak I., J. Microencapsul., 15, 237-252 (1998).
29. Carr R. L., Chem. Eng., 72, 69-72 (1965).
30. Khan M. Z. I., Rausl D., Zanoski R., Zidar S., Horvat-Mikulcic J., Krizmanic L., Eskinja M., Mildner B., Knezevic Z., Biol. Pharm. Bull., 27, 1630-1635 (2004).
31. Langenbucher F., Pharm. Ind., 44, 1166-1171 (1982).
32. Farre M., Roset P. N., Abandes S., Menoyo E., Alvarez Y., Rovira M., Baena A., Methods Find. Exp. Clin. Pharmacol., 30, 37-41 (2008).
33. Gramatte T., Richter K., Br. J. Clin. Pharmacol., 37, 608-611 (1994).